Literature DB >> 15489359

Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Gadi Borkow1, Zvi Bentwich.   

Abstract

Chronic immune activation is one of the hallmarks of human immunodeficiency virus (HIV) infection. It is present also, with very similar characteristics, in very large human populations infested with helminthic infections. We have tried to review the studies addressing the changes in the immune profiles and responses of hosts infected with either one of these two chronic infections. Not surprisingly, several of the immune derangements and impairments seen in HIV infection, and considered by many to be the "specific" effects of HIV, can be found in helminth-infected but HIV-noninfected individuals and can thus be accounted for by the chronic immune activation itself. A less appreciated element in chronic immune activation is the immune suppression and anergy which it may generate. Both HIV and helminth infections represent this aspect in a very wide and illustrative way. Different degrees of anergy and immune hyporesponsiveness are present in these infections and probably have far-reaching effects on the ability of the host to cope with these and other infections. Furthermore, they may have important practical implications, especially with regard to protective vaccinations against AIDS, for populations chronically infected with helminths and therefore widely anergic. The current knowledge of the mechanisms responsible for the generation of anergy by chronic immune activation is thoroughly reviewed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15489359      PMCID: PMC523563          DOI: 10.1128/CMR.17.4.1012-1030.2004

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  264 in total

Review 1.  Cellular immune responses to HIV.

Authors:  A J McMichael; S L Rowland-Jones
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

2.  Signals transduced through the CD4 molecule interfere with TCR/CD3-mediated ras activation leading to T cell anergy/apoptosis.

Authors:  S M Tamma; N Chirmule; T W McCloskey; N Oyaizu; V S Kalyanaraman; S Pahwa
Journal:  Clin Immunol Immunopathol       Date:  1997-11

Review 3.  Dynamics of HIV-1 and CD4+ lymphocytes in vivo.

Authors:  A S Perelson; P Essunger; D D Ho
Journal:  AIDS       Date:  1997       Impact factor: 4.177

Review 4.  The role of CD28 costimulation in the generation of cytotoxic T lymphocytes.

Authors:  M Azuma; L L Lanier
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

5.  Morbidity and mortality due to ascariasis: re-estimation and sensitivity analysis of global numbers at risk.

Authors:  N R de Silva; M S Chan; D A Bundy
Journal:  Trop Med Int Health       Date:  1997-06       Impact factor: 2.622

6.  Transmission intensity determines lymphocyte responsiveness and cytokine bias in human lymphatic filariasis.

Authors:  C L King; M Connelly; M P Alpers; M Bockarie; J W Kazura
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

Review 7.  Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection.

Authors:  J Lieberman; P Shankar; N Manjunath; J Andersson
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

Review 8.  TGF beta and HIV infection.

Authors:  M Lotz; P Seth
Journal:  Ann N Y Acad Sci       Date:  1993-06-23       Impact factor: 5.691

9.  Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

Authors:  M Clerici; J V Giorgi; C C Chou; V K Gudeman; J A Zack; P Gupta; H N Ho; P G Nishanian; J A Berzofsky; G M Shearer
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

Review 10.  The immune response and immunopathology in infection with Schistosoma mansoni: a key role of major egg antigen Sm-p40.

Authors:  M J Stadecker; H J Hernandez
Journal:  Parasite Immunol       Date:  1998-05       Impact factor: 2.280

View more
  56 in total

1.  Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy.

Authors:  T Resende Co; C S Hirsch; Z Toossi; R Dietze; R Ribeiro-Rodrigues
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

2.  Helminth infections predispose mice to pneumococcal pneumonia but not to other pneumonic pathogens.

Authors:  Nopporn Apiwattanakul; Paul G Thomas; Raymond E Kuhn; De'Broski R Herbert; Jonathan A McCullers
Journal:  Med Microbiol Immunol       Date:  2014-06-21       Impact factor: 3.402

3.  Changes in plasma cytokines after treatment of ascaris lumbricoides infection in individuals with HIV-1 infection.

Authors:  Catherine A Blish; Laura Sangaré; Bradley R Herrin; Barbra A Richardson; Grace John-Stewart; Judd L Walson
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

4.  Schistosomiasis Induces Persistent DNA Methylation and Tuberculosis-Specific Immune Changes.

Authors:  Andrew R DiNardo; Tomoki Nishiguchi; Emily M Mace; Kimal Rajapakshe; Godwin Mtetwa; Alexander Kay; Gugu Maphalala; W Evan Secor; Rojelio Mejia; Jordan S Orange; Cristian Coarfa; Kapil N Bhalla; Edward A Graviss; Anna M Mandalakas; George Makedonas
Journal:  J Immunol       Date:  2018-05-11       Impact factor: 5.422

5.  Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.

Authors:  Judd L Walson; Phelgona A Otieno; Margaret Mbuchi; Barbra A Richardson; Barbara Lohman-Payne; Steve Wanyee Macharia; Julie Overbaugh; James Berkley; Eduard J Sanders; Michael H Chung; Grace C John-Stewart
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

6.  Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS?

Authors:  Eduardo Samo Gudo; Nilesh B Bhatt; Dulce Ramalho Bila; Celina Monteiro Abreu; Amílcar Tanuri; Wilson Savino; Suse Dayse Silva-Barbosa; Ilesh V Jani
Journal:  BMC Infect Dis       Date:  2009-12-22       Impact factor: 3.090

7.  Prevalence and correlates of helminth co-infection in Kenyan HIV-1 infected adults.

Authors:  Judd L Walson; Barclay T Stewart; Laura Sangaré; Loice W Mbogo; Phelgona A Otieno; Benjamin K S Piper; Barbra A Richardson; Grace John-Stewart
Journal:  PLoS Negl Trop Dis       Date:  2010-03-30

8.  Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10.

Authors:  Akram A Da'dara; Donald A Harn
Journal:  Vaccine       Date:  2009-11-24       Impact factor: 3.641

Review 9.  Do antenatal parasite infections devalue childhood vaccination?

Authors:  A Desiree Labeaud; Indu Malhotra; Maria J King; Christopher L King; Charles H King
Journal:  PLoS Negl Trop Dis       Date:  2009-05-26

10.  Intestinal parasitic infections in relation to HIV/AIDS status, diarrhea and CD4 T-cell count.

Authors:  Shimelis Assefa; Berhanu Erko; Girmay Medhin; Zelalem Assefa; Techalew Shimelis
Journal:  BMC Infect Dis       Date:  2009-09-18       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.